Cue Advisory Services’s AbbVie ABBV Stock Holding History

Cue Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,729	Closed	-$1.01M	–	2
2018 Q3	$1.01M	Sell	10,729 -56	-0.5%	-$5.31K	0.61%	57
2018 Q2	$999K	Buy	10,785 +40	+0.4%	+$3.91K	0.61%	58
2018 Q1	$1.02M	Buy	10,745 +1,520	+16%	+$167K	0.67%	53
2017 Q4	$892K	Sell	9,225 -145	-2%	-$13.7K	0.59%	61
2017 Q3	$833K	Sell	9,370 -453	-5%	-$34.5K	0.58%	65
2017 Q2	$712K	Sell	9,823 -315	-3%	-$21.2K	0.51%	72
2017 Q1	$661K	Buy	10,138 +1,200	+13%	+$75.4K	0.5%	73
2016 Q4	$560K	Buy	8,938 +1,751	+24%	+$107K	0.45%	82
2016 Q3	$453K	Buy	7,187 +65	+0.9%	+$4.21K	0.38%	96
2016 Q2	$441K	Buy	7,122 +250	+4%	+$15.2K	0.38%	94
2016 Q1	$393K	Buy	6,872 +195	+3%	+$10.9K	0.34%	98
2015 Q4	$396K	Sell	6,677 -325	-5%	-$18.7K	0.36%	93
2015 Q3	$381K	Buy	+7,002	New	+$456K	0.4%	85

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cue Advisory Services's ABBV Position: Q4 2018 in Review

Cue Advisory Services sold out of AbbVie (ABBV) in Q4 2018, closing a stake of 10,729 shares — an estimated $1.01M sold.

Cue Advisory Services first reported a position in ABBV in Q3 2015 and held it in 13 quarters. The position peaked at $1.02M in Q1 2018. 2,062 funds tracked by Wall St. Rank hold ABBV as of Q4 2018.

Cue Advisory Services reported no remaining AbbVie position as of Q4 2018 after selling out during the quarter.
Cue Advisory Services sold 10,729 AbbVie shares in Q4 2018, an estimated $1.01M.
Cue Advisory Services first reported a position in AbbVie in Q3 2015 and held it in 13 quarters.
Cue Advisory Services's AbbVie position peaked at $1.02M in Q1 2018.
2,062 funds tracked by Wall St. Rank held AbbVie as of Q4 2018.

Based on Cue Advisory Services's 13F filing for Q4 2018.